.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
Fuji
Queensland Health
US Army
McKinsey
Teva
Argus Health
Cerilliant

Generated: September 24, 2017

DrugPatentWatch Database Preview

Timolol maleate - Generic Drug Details

« Back to Dashboard

What are the generic sources for timolol maleate and what is the scope of timolol maleate freedom to operate?

Timolol maleate
is the generic ingredient in six branded drugs marketed by Usl Pharma, Apotex Inc, Akorn, Bausch And Lomb, Merck, Watson Labs, Valeant Pharms Llc, Pacific Pharma, Teva, Sandoz, Fdc Ltd, Sandoz Inc, Hi Tech Pharma, Aton, Quantum Pharmics, Fougera, Mylan, and Wockhardt, and is included in forty-three NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Timolol maleate has twenty-seven patent family members in eighteen countries.

There are fifteen drug master file entries for timolol maleate. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: timolol maleate

Tradenames:6
Patents:3
Applicants:18
NDAs:43
Drug Master File Entries: see list15
Suppliers / Packagers: see list17
Bulk Api Vendors: see list56
Clinical Trials: see list329
Patent Applications: see list6,357
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:timolol maleate at DailyMed

Pharmacology for Ingredient: timolol maleate

Tentative approvals for TIMOLOL MALEATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.5%SOLUTION;OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC074465-001Mar 25, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
BLOCADREN
timolol maleate
TABLET;ORAL018017-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
TIMOLOL MALEATE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC020963-001Oct 21, 1998ABRXNoNo► Subscribe► SubscribeY► Subscribe
Mylan
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072668-003Jun 8, 1990RXNoNo► Subscribe► Subscribe► Subscribe
Hi Tech Pharma
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC075163-001Sep 10, 2002AT1RXNoNo► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-001Nov 5, 1986RXYesYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
ISTALOL
timolol maleate
SOLUTION/DROPS;OPHTHALMIC021516-001Jun 4, 2004AT2RXYesYes► Subscribe► SubscribeY ► Subscribe
Bausch And Lomb
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC074776-001Mar 25, 1997AT1RXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC078771-002Sep 28, 2009AT1RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: timolol maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-002Nov 5, 1986► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck
BLOCADREN
timolol maleate
TABLET;ORAL018017-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant Pharms Llc
TIMOPTIC-XE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-001Nov 4, 1993► Subscribe► Subscribe
Valeant Pharms Llc
TIMOPTIC-XE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-001Nov 4, 1993► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck
BLOCADREN
timolol maleate
TABLET;ORAL018017-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-002Nov 5, 1986► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-001Nov 5, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: timolol maleate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,261,547 Gelling ophthalmic compositions containing xanthan gum► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: timolol maleate

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9922715► Subscribe
Germany69909768► Subscribe
China1278162► Subscribe
Canada2307303► Subscribe
Brazil9910113► Subscribe
Canada2322579► Subscribe
New Zealand506921► Subscribe
Japan2002510654► Subscribe
China1133466► Subscribe
Argentina016460► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: TIMOLOL MALEATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90041Netherlands► SubscribePRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306
00C/001Belgium► SubscribePRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306
C/GB99/043United Kingdom► SubscribePRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804
/1999Austria► SubscribePRODUCT NAME: DORZOLAMID ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE DORZOLAMIDHYDROCHLORID, UND TIMOLOL ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE TIMOLOLMALEAT; NAT. REGISTRATION NO/DATE: 1-22701, 1-22702 19980828; FIRST REGISTRATION: DK 9794 19980306
C0013Belgium► SubscribePRODUCT NAME: TIMOLOLI MALEAS EQ. TIMOLOLUM; NATIONAL REGISTRATION/DATE: 922 IS 166 F 13 19950627; FIRST REGISTRATION: SE 11901 19930910
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Fuji
McKinsey
Merck
Medtronic
Johnson and Johnson
QuintilesIMS
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot